Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-blind, Double-simulated, Placebo Parallel-controlled, Multicenter Clinical Study on Safety and Efficacy of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children

NCT05859984 is registered in ClinicalTrials.gov with Seventh Medical Center of PLA General Hospital as lead sponsor.

NCT NCT05859984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05859984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-blind, Double-simulated, Placebo Parallel-controlled, Multicenter Clinical Study on Safety and Efficacy of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children
Lead sponsor
Seventh Medical Center of PLA General Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2023
Completion date
May 31, 2024
Enrollment
345 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

viral upper respiratory tract infection